Elite Pharmaceuticals, Inc. specializes in the development of oral controlled release products, such as delayed, sustained, targeted and pulsatile release tables, pellets, capsules, granules and powders.  The Company’s primary focus is in the therapeutic areas of pain management, allergy, cardiovascular and infection.

  Recent Press Releases:

2/22/2010	Elite Pharmaceuticals, Inc. 3rd Quarter 2010 Financial Results …Revenue increased 287% for the comparable period of the prior year
2/16/2010	Elite Pharmaceuticals, Inc. To Host Quarterly Conference Call on Friday, February 19, 2010
12/2/2009	ELITE PHRAMACEUTALS AND THEPHARMANETWORK ANNOUNCE FDA APPROVAL FOR GENERIC METHADONE TABLETS
11/16/2009	Elite Pharmaceuticals, Inc. To Host Quarterly Conference Call on Wednesday, November 18, 2009
11/5/2009	ELITE PHARMACEUTICALS, INC. ANNOUNCES SECOND CLOSING OF STRATEGIC ALLIANCE AGREEMENT WITH EPIC PHARMA